DAA-mediated HCV cure reduces HIV DNA levels in HCV/HIV coinfected people
Authors: Gobran ST, Pagliuzza A, Khedr O, Fert A, Chomont N, Bruneau J, Klein MB, Ancuta P, Shoukry NH
Journal: Journal of Virology
Feasibility of hepatitis C elimination by screening and treatment alone in high-income countries
Authors: Tian F, Forouzannia F, Feng Z, Biondi M, Mendlowitz A, Feld J, Sander B, Wong W.W.L.
Journal: Hepatology
HCV infection characteristics, treatment uptake and outcomes in patient with diabetes mellitus
Authors: Marina Angel, Yelena Petrosyan, Mary-Anne Doyle and Curtis Cooper
Journal: BMC Endocrine Disorders
Resistance-Associated Substitution Testing Trends and Impact on HCV Treatment Outcomes in Canada: A CanHepC-CANUHC Analysis
Authors: Himain Perera, Haris Imsirovic, Gisela Macphail, Duncan Webster, Chris Fraser, Sergio Borgia, Hongqun Liu, Sam Lee, Jordan J. Feld, Curtis Cooper, the Canadian Network Undertaking Against Hepatitis C (CANUHC) Cohort Investigator Team
Journal: Journal of Viral Hepatitis
Uptake and factors associated with direct-acting antiviral therapy for hepatitis C and treatment outcomes among Canadian immigrants: A retrospective cohort analysis
Authors: Yelena Petrosyan, John-Graydon Simmons, Erin Kelly, and Curtis L Cooper
Journal: Canadian Liver Journal
Postal address
University Health Network
Toronto General Hospital
200 Elizabeth Street, 9EB-240
Toronto (ON) M5G 2C4
CanHepC's administrative office is situated on the traditional territories of the Mississaugas of the Credit, the Anishnabeg, the Haudenosaunee and the Wendat peoples. Toronto is covered by Treaty 13 with the Mississaugas of the Credit.
© 2025 CanHepC - Canadian Network on Hepatitis C. All Rights Reserved.
